Current Assets
Restricted Cash
Boston Scientific Restricted Cash decreased by 27.6% to $71M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31.1%, from $103M to $71M. Over 4 years (FY 2020 to FY 2024), Restricted Cash shows a downward trend with a -14.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2016
Last reportedQ1 2026May 1, 2026
Metric ID:
restricted_cashHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $167M | $155M | $188M | $146M | $132M | $112M | $149M | $135M | $135M | $123M | $130M | $93M | $75M | $70M | $111M | $103M | $109M | $98M | $71M |
| QoQ Change | — | -7.2% | +21.3% | -22.3% | -9.6% | -15.2% | +33.0% | -9.4% | +0.0% | -8.9% | +5.7% | -28.5% | -19.4% | -6.7% | +58.6% | -7.2% | +5.8% | -10.1% | -27.6% |
| YoY Change | — | — | — | — | -21.0% | -27.7% | -20.7% | -7.5% | +2.3% | +9.8% | -12.8% | -31.1% | -44.4% | -43.1% | -14.6% | +10.8% | +45.3% | +40.0% | -31.1% |
Range$70M – $188M
CAGR-17.3%
Avg YoY Growth-9.7%
Median YoY Growth-14.6%
Current Streak2 quarters decline
Restricted Cash at Other Companies
Frequently Asked Questions
- What is Boston Scientific's restricted cash?
- Boston Scientific (BSX) reported restricted cash of $71M in Q1 2026.
- How has Boston Scientific's restricted cash changed year-over-year?
- Boston Scientific's restricted cash decreased by 31.1% year-over-year, from $103M to $71M.
- What is the long-term trend for Boston Scientific's restricted cash?
- Over 4 years (2020 to 2024), Boston Scientific's restricted cash has grown at a -14.5% compound annual growth rate (CAGR), from $208M to $111M.